India, Sept. 19 -- In a move to combat the rising tide of synthetic narcotics threatening public safety, the United States of America Embassy in New Delhi has revoked and denied visas for several Indian business executives and corporate leaders involved in trafficking fentanyl precursor chemicals. This action is part of the Trump administration's broader strategy to curb the influx of deadly synthetic opioids into the US.

The visa restrictions have been imposed under provisions of the Immigration and Nationality Act, which enable the US Government to deny entry to individuals involved in illegal activities, including drug trafficking. In addition to denying visas to the executives, the US Embassy has flagged individuals associated with c...